Triggering the succinate receptor GPR91 on dendritic cells enhances immunity

Nature Immunology

Volumn 9, Issue 11, 2008, Pages 1261-1269

  Rubic, Tina ^a,b   Lametschwandtner, Günther ^a   Jost, Sandra ^a   Hinteregger, Sonja ^a   Kund, Julia ^a   Carballido Perrig, Nicole ^a,b   Schwärzler, Christoph ^a,b   Junt, Tobias ^a,b   Voshol, Hans ^b   Meingassner, Josef G ^a   Mao, Xiaohong ^c   Werner, Gudrun ^a   Rot, Antal ^a   Carballido, José M ^a,b  

^a Novartis Institutes for BioMedical Research Vienna   (Austria)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 91; IMMUNOLOGICAL ADJUVANT; LIGAND; SUCCINIC ACID; TETANUS TOXOID; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MIGRATION; CELL RESPIRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG RESEARCH; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LANGERHANS CELL; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SKIN ALLOGRAFT; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; LANGERHANS CELLS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SUCCINIC ACID; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 54549089749     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1657     Document Type: Article

References (28)

1. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
2. Parker, L.C., Prince, L.R. & Sabroe, I. Translational mini-review series on Toll-like receptors: Networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin. Exp. Immunol. 147 199-207 (2007).
3. Sallusto, F. et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769 (1998).
4. Marsland, B.J. et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22, 493-505 (2005).
5. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
6. Oppenheim, J.J. & Yang, D. Alarmins: Chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365 (2005).
7. He, W.H. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188-193 (2004).
8. Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
9. Larrick, J.W., Fischer, D.G., Anderson, S.J. & Koren, H.S. Characterization of a human macrophage-like cell-line stimulated in vitro - a model of macrophage functions. J. Immunol. 125, 6-12 (1980).
10. Kono, H. & Rock, K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008).
11. Xu, G. & Shi, Y. Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res. 17, 759-771 (2007).
12. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999).
13. Shi, Y., Zheng, W. & Rock, K.L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 97, 14590-14595 (2000).
14. Shi, Y., Evans, J.E. & Rock, K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 516-521 (2003).
15. Kool, M. et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205, 869-882 (2008).
16. Shi, Y., Galusha, S.A. & Rock, K.L. Cutting edge: Elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176, 3905-3908 (2006).
17. Kushnir, M.M., Komaromy-Hiller, G., Shushan, B., Urry, F.M. & Roberts, W.L. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin. Chem. 47, 1993-2002 (2001).
18. Rotstein, O.D., Pruett, T.L., Fiegel, V.D., Nelson, R.D. & Simmons, R.L. Succinic acid, a metabolic by-product of bacteroides species, inhibits polymorphonuclear leukocyte function. Infect. Immun. 48, 402-408 (1985).
19. Correa, P.R. et al. Succinate is a paracrine signal for liver damage. J. Hepatol. 47, 262-269 (2007).
20. Fiers, W., Beyaert, R., Declercq, W. & Vandenabeele, P. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730 (1999).
21. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22, 643-654 (2005).
22. Müller-Decker, K., Fürstenberger, G. & Marks, F. Keratinocyte-derived pro-inflammatory key mediators and cell viability as in vitro parameters of irritancy: A possible alternative to the Draize skin irritation test. Toxicol. Appl. Pharmacol. 127, 99-108 (1994).
23. Matzinger, P. The danger model: A renewed sense of self. Science 296, 301-305 (2002).
24. Winau, F. et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26, 117-129 (2007).
25. Charbonnier, A.S. et al. Macrophage inflammatory protein 3 α is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190, 1755-1767 (1999).
26. H1-like cytokine production and migratory capacities. J. Allergy Clin. Immunol. 113, 987-994 (2004).
27. Pawlak, M. et al. Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis. Proteomics 2, 383-393 (2002).
28. Wulfkuhle, J.D. et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3, 2085-2090 (2003).